Miaki Uzu, Toshiaki Takezawa. Novel cell culture technology to harvest hepatic metabolites accumulated in the bile canaliculus-like structures between HepG2-NIAS cells utilizing crosstalk with TFK-1 cells. Nano Biomedicine. 2023. 15. 2. 75-87
Miaki Uzu, Toshiaki Takezawa. A Hybrid Human Microvascular Endothelial Cell Line Created by Utilizing a Cell Fusion Technique and Its Advantage for Expressing High Endothelial Barrier Function. Nano Biomedicine. 2022. 14. 1. 9-17
Kanako Miyano, Seiya Hasegawa, Noriho Asai, Miaki Uzu, Wakako Yatsuoka, Takao Ueno, Miki Nonaka, Hideaki Fujii, Yasuhito Uezono. The Japanese Herbal Medicine Hangeshashinto Induces Oral Keratinocyte Migration by Mediating the Expression of CXCL12 Through the Activation of Extracellular Signal-Regulated Kinase. Frontiers in Pharmacology. 2022. 12
Kanako Miyano, Minori Ikehata, Kaori Ohshima, Yuki Yoshida, Yasuhiro Nose, Sei-Ichi Yoshihara, Katsuyuki Oki, Seiji Shiraishi, Miaki Uzu, Miki Nonaka, et al. Intravenous administration of human mesenchymal stem cells derived from adipose tissue and umbilical cord improves neuropathic pain via suppression of neuronal damage and anti-inflammatory actions in rats. PloS one. 2022. 17. 2. e0262892
Toshiaki Takezawa, Miaki Uzu. HepG2-NIAS cells, a new subline of HepG2 cells that can enhance not only CYP3A4 activity but also expression of drug transporters and form bile canaliculus-like networks by the oxygenation culture via a collagen vitrigel membrane. The Journal of Toxicological Sciences. 2022. 47. 1. 39-50
